跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROLIA denosumab (rch) 60mg/1mL solution for injection prefilled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
PROLIA denosumab (rch) 60mg/1mL solution for injection prefilled syringe
Approved
STANDARD
PROLIA denosumab (rch) 60mg/1mL solution for injection prefilled syringe
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
7875101dd8ecd112
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7875101dd8ecd112
Product Name
PROLIA denosumab (rch) 60mg/1mL solution for injection prefilled syringe
Artg Id
159322
Artg Name
PROLIA denosumab (rch) 60mg/1mL solution for injection prefilled syringe
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2010-06-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-07242-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
7875101dd8ecd112
Type
Standard
Back to TGA Approvals